Previous studies showed that the elevation of circulating FGF21 was closely associated with metabolic disorders including obesity, diabetes and metabolic syndrome (MetS) [3, 6]. The gene discussed is FGF21; the disease is obesity due to melanocortin 4 receptor deficiency.